Stay updated with breaking news from Pulseselect System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Pulsed Field Ablation Market- By Therapeutic...
/PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its PulseSelect™ Pulsed Field Ablation (PFA) System...
Medtronic (NYSE:MDT) announced today that its PulseSelect pulsed-field ablation (PFA) system exceeded its safety performance goal.
The Herald News FALL RIVER – Southcoast Health is enrolling patients in a new clinical trial to evaluate the use of a new heart ablation technology designed to treat atrial fibrillation. The community health system’s Cardiovascular Care Center at Charlton Memorial Hospital was the first in the world to perform the procedure during the pivotal phase of the research trial that precedes FDA approval, said Southcoast Clinical Research Coordinator Debra Benevides. The investigational device exemption pivotal trial is called Pulsed AF and utilizes the Medtronic PulseSelect Pulsed Field Ablatio...
Medtronic Announces First Procedures in Pivotal Trial to Evaluate Novel Ablation Technology in Treating Atrial Fibrillation Study Will Determine the Safety and Effectiveness of Pulsed Electrical Fields to Interrupt Irregular Heart Rhythms Medtronic plc the global leader in medical technology, today announced the first procedures in the investigational device exemption pivotal trial to evaluate the PulseSelect ™ Pulsed Field Ablation System, a novel, breakthrough technology that uses pulsed electric fields to treat atrial fibrillation . … Study Will Determine the Safety and Effectiveness ...